Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Kazuo Sasamoto"'
Autor:
Hiroshi Sakura, Naotake Hashimoto, Kazuo Sasamoto, Hiroshi Ohashi, Sumiko Hasumi, Noriko Ujihara, Tadasu Kasahara, Osamu Tomonaga, Hideo Nunome, Masashi Honda, Yasuhiko Iwamoto, for the JAMP Study Investigators
Publikováno v:
BMC Endocrine Disorders, Vol 16, Iss 1, Pp 1-11 (2016)
Abstract Background To investigate the ameliorating effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood glucose control in patients with type 2 diabetes mellitus who were previously untreated with or who have a poor responsive to exis
Externí odkaz:
https://doaj.org/article/abc9e6be1d1948a0bd3612a4e055e032
Autor:
Yasuhiko Iwamoto, Kazuo Sasamoto, Sumiko Hasumi, Hideo Nunome, Hiroshi Sakura, Noriko Ujihara, Naotake Hashimoto, Masashi Honda, Tadasu Kasahara, Hiroshi Ohashi, Osamu Tomonaga
Publikováno v:
Journal of Diabetes Investigation
Aims/Introduction Hemoglobin A1c (HbA1c) levels in patients with type 2 diabetes mellitus fluctuate throughout the year. However, there are few studies that have evaluated the therapeutic effect of hypoglycemic agents while considering such fluctuati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cee5d8436682c6d27397dae0dcbfc55
https://doi.org/10.1111/jdi.12817
https://doi.org/10.1111/jdi.12817
Autor:
Noriko, Ujihara, Hiroshi, Sakura, Naotake, Hashimoto, Kazuo, Sasamoto, Hiroshi, Ohashi, Sumiko, Hasumi, Tadasu, Kasahara, Osamu, Tomonaga, Hideo, Nunome, Masashi, Honda, Yasuhiko, Iwamoto, Yukinobu, Kobayashi
Publikováno v:
Diabetology international. 9(1)
[This corrects the article DOI: 10.1007/s13340-017-0330-2.].
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::92bd4b977ba22f332f68acf15675e9f6
https://pubmed.ncbi.nlm.nih.gov/30603350
https://pubmed.ncbi.nlm.nih.gov/30603350
Autor:
Hideo, Nunome, Hiroshi, Sakura, Naotake, Hashimoto, Kazuo, Sasamoto, Hiroshi, Ohashi, Sumiko, Hasumi, Noriko, Ujihara, Tadasu, Kasahara, Osamu, Tomonaga, Masashi, Honda, Yasuhiko, Iwamoto, Yukinobu, Kobayashi
As a subanalysis of the Januvia Multicenter Prospective Trial in Type 2 Diabetes (JAMP study), we examined factors that decreased blood glucose control effect of sitagliptin after 3 months and patients requiring an addition or increase of diabetes tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c94b48636484fb9a31c7b8f4f016d781
https://europepmc.org/articles/PMC6224911/
https://europepmc.org/articles/PMC6224911/
Autor:
Hiroshi Sakura, Tadasu Kasahara, Naotake Hashimoto, Masashi Honda, Sumiko Hasumi, Yasuhiko Iwamoto, Hideo Nunome, Osamu Tomonaga, Noriko Ujihara, Hiroshi Ohashi, Kazuo Sasamoto
Publikováno v:
Journal of Clinical Medicine Research
Background: The aim of the study was to determine the effects of sitagliptin on renal function in a diabetic population including patients with normal renal function. Methods: We analyzed the association between 12-month, 50 mg/day sitagliptin and re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54d6b38b47871fa601c53bb9b438f95c
https://pubmed.ncbi.nlm.nih.gov/29238432
https://pubmed.ncbi.nlm.nih.gov/29238432
Autor:
Noriko, Ujihara, Hiroshi, Sakura, Naotake, Hashimoto, Kazuo, Sasamoto, Hiroshi, Ohashi, Sumiko, Hasumi, Tadasu, Kasahara, Osamu, Tomonaga, Hideo, Nunome, Masashi, Honda, Yasuhiko, Iwamoto, Yukinobu, Kobayashi
To determine the efficacy and safety of sitagliptin when used with some therapeutic drugs to treat elderly patients. Sitagliptin (50 mg/day) was added to the pre-existing therapy for type 2 diabetes. Changes in the glycated hemoglobin (HbA1c) level a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28bcc628e0b5943ab45db309bfdc6bfc
https://europepmc.org/articles/PMC6224874/
https://europepmc.org/articles/PMC6224874/
Autor:
Yasue Omori, Satomi Shibasaki, Teiko Amemiya, Kazuo Sasamoto, Munehiro Miyamae, Naomi Shibata, Rieko Totani, Reiko Kawahara
Publikováno v:
The Journal of Japan Atherosclerosis Society. 21:67-75
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9091f802fc94025067f1e706517bcbe5
https://doi.org/10.5551/jat1973.21.1-2_67
https://doi.org/10.5551/jat1973.21.1-2_67
Autor:
Toshikazu Yamanouchi, Tatsuo Yanagawa, Kazuo Sasamoto, Atsushi Araki, Mariko Miyao, Satoru Yamada
Publikováno v:
Metabolism: clinical and experimental. 55(1)
We investigated the meaning and the worth of lowering low-density lipoprotein cholesterol (LDL-C) to less than 100 mg/dL in Japanese type 2 diabetic patients using atorvastatin. As a multicenter open-labeled study, 84 type 2 diabetic Japanese patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec4cda9bdb9c8c3ea9d5d3132af32a86
https://pubmed.ncbi.nlm.nih.gov/16324921
https://pubmed.ncbi.nlm.nih.gov/16324921
Publikováno v:
Diabetes research and clinical practice. 24(3)
We investigated the follow-up status and prognosis of 109 patients with non-insulin-dependent diabetes mellitus aged from 10 to 19 years old (66 males and 43 females). Patients who had not attended hospital for at least 20 months up to the end of Sep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad7c60ef3f8bb2826c8db8c545042a10
https://pubmed.ncbi.nlm.nih.gov/7988350
https://pubmed.ncbi.nlm.nih.gov/7988350